Niki I. Paphitou

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

Alessandro Cassini, Liselotte Diaz Högberg, Diamantis Plachouras et al. · The Lancet Infectious Diseases · 2018 · 2.9K citations · Full text

Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey

Ann Versporten, Peter Zarb, Isabelle Caniaux et al. · The Lancet Global Health · 2018 · 656 citations · Full text

Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials

Niki I. Paphitou, Luis Ostrosky‐Zeichner, John Rex · Medical Mycology · 2005 · 179 citations · Full text

In Vitro Antifungal Susceptibilities of <i>Trichosporon</i> Species

Niki I. Paphitou, Luis Ostrosky‐Zeichner, Victor L. Paetznick et al. · Antimicrobial Agents and Chemotherapy · 2002 · 176 citations · Full text

In Vitro Activities of Investigational Triazoles against<i>Fusarium</i>Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results

Niki I. Paphitou, Luis Ostrosky‐Zeichner, Victor L. Paetznick et al. · Antimicrobial Agents and Chemotherapy · 2002 · 78 citations · Full text

Antifungal Agent, Fusarium Isolates, Health Sciences +12